Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1289, 2001-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Linezolid: some advantages over vancomycin in MRS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. :
Dalbavancin equivalent to linezolid, cefazolin, vancomycin for SSTI
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
IV vancomycin to oral linezolid switch potentially cost saving
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
IV vancomycin to oral linezolid switch potentially cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. :